Semler Scientific ROA 2013-2025 | SMLR
Current and historical return on assets (ROA) values for Semler Scientific (SMLR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Semler Scientific ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $-0.03B | $0.29B | -16.90% |
| 2024-12-31 | $0.04B | $0.24B | 32.73% |
| 2024-09-30 | $0.02B | $0.09B | 18.88% |
| 2024-06-30 | $0.02B | $0.09B | 19.63% |
| 2024-03-31 | $0.02B | $0.08B | 27.85% |
| 2023-12-31 | $0.02B | $0.08B | 27.81% |
| 2023-09-30 | $0.02B | $0.08B | 27.87% |
| 2023-06-30 | $0.02B | $0.08B | 26.77% |
| 2023-03-31 | $0.02B | $0.07B | 25.40% |
| 2022-12-31 | $0.01B | $0.06B | 23.63% |
| 2022-09-30 | $0.01B | $0.06B | 23.11% |
| 2022-06-30 | $0.01B | $0.06B | 24.19% |
| 2022-03-31 | $0.02B | $0.06B | 31.53% |
| 2021-12-31 | $0.02B | $0.05B | 38.10% |
| 2021-09-30 | $0.02B | $0.05B | 48.55% |
| 2021-06-30 | $0.02B | $0.05B | 58.67% |
| 2021-03-31 | $0.02B | $0.04B | 51.20% |
| 2020-12-31 | $0.01B | $0.04B | 53.85% |
| 2020-09-30 | $0.01B | $0.03B | 55.17% |
| 2020-06-30 | $0.02B | $0.02B | 76.92% |
| 2020-03-31 | $0.02B | $0.02B | 101.49% |
| 2019-12-31 | $0.02B | $0.02B | 114.29% |
| 2019-09-30 | $0.01B | $0.02B | 121.74% |
| 2019-06-30 | $0.01B | $0.01B | 82.35% |
| 2019-03-31 | $0.01B | $0.01B | 68.97% |
| 2018-12-31 | $0.00B | $0.01B | 66.67% |
| 2018-09-30 | $0.00B | $0.01B | 60.00% |
| 2018-06-30 | $0.00B | $0.01B | 47.06% |
| 2018-03-31 | $0.00B | $0.00B | 0.00% |
| 2017-12-31 | $0.00B | $0.00B | -57.14% |
| 2017-09-30 | $0.00B | $0.00B | -61.54% |
| 2017-06-30 | $0.00B | $0.00B | -66.67% |
| 2017-03-31 | $0.00B | $0.00B | -66.67% |
| 2016-12-31 | $0.00B | $0.00B | -66.67% |
| 2016-09-30 | $-0.01B | $0.00B | -200.00% |
| 2016-06-30 | $-0.01B | $0.00B | -246.15% |
| 2016-03-31 | $-0.01B | $0.00B | -200.00% |
| 2015-12-31 | $-0.01B | $0.00B | -168.42% |
| 2015-09-30 | $-0.01B | $0.00B | -83.33% |
| 2015-06-30 | $0.00B | $0.01B | -59.26% |
| 2015-03-31 | $0.00B | $0.01B | -55.17% |
| 2014-12-31 | $0.00B | $0.01B | -50.00% |
| 2014-09-30 | $0.00B | $0.01B | -61.54% |
| 2014-06-30 | $0.00B | $0.01B | -84.21% |
| 2014-03-31 | $0.00B | $0.01B | -145.45% |
| 2013-12-31 | $0.00B | $0.00B | -800.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.456B | $0.056B |
| Semler Scientific, Inc. is a medical risk-assessment company. The Company engages in developing, manufacturing, and marketing patented products that identify the risk profile of medical patients to allow healthcare providers to capture full reimbursement potential for their services. Its products include FloChec (R) which is used in the office setting to allow healthcare providers to measure arterial blood flow in the extremities and is a useful tool for internists and primary care physicians. Semler Scientific, Inc. is headquartered in Portland, Oregon. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $202.004B | 88.48 |
| Thermo Fisher Scientific (TMO) | United States | $155.550B | 18.82 |
| Edwards Lifesciences (EW) | United States | $45.755B | 30.00 |
| Alcon (ALC) | Switzerland | $44.308B | 29.94 |
| IDEXX Laboratories (IDXX) | United States | $41.667B | 47.88 |
| DexCom (DXCM) | United States | $33.517B | 51.81 |
| STERIS (STE) | Ireland | $24.719B | 27.26 |
| IQVIA Holdings (IQV) | United States | $24.708B | 13.84 |
| Mettler-Toledo (MTD) | United States | $24.055B | 28.61 |
| Waters (WAT) | United States | $21.392B | 30.18 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.121B | 0.00 |
| Hologic (HOLX) | United States | $12.655B | 13.75 |
| Penumbra (PEN) | United States | $10.870B | 85.31 |
| Sysmex ADR (SSMXY) | Japan | $10.657B | 30.23 |
| Masimo (MASI) | United States | $8.438B | 31.12 |
| Globus Medical (GMED) | United States | $8.424B | 19.76 |
| Teleflex (TFX) | United States | $5.713B | 9.43 |
| Glaukos (GKOS) | United States | $5.455B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.222B | 22.12 |
| TransMedics (TMDX) | United States | $4.112B | 89.40 |
| PROCEPT BioRobotics (PRCT) | United States | $3.213B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.421B | 14.42 |
| Veracyte (VCYT) | United States | $2.287B | 32.09 |
| Nihon Kohden (NHNKY) | Japan | $2.213B | 25.38 |
| Elekta AB (EKTAY) | Sweden | $2.048B | 18.41 |
| Alphatec Holdings (ATEC) | United States | $1.894B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.537B | 0.00 |
| Artivion (AORT) | United States | $1.260B | 118.04 |
| Pulse Biosciences (PLSE) | United States | $1.156B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.055B | 5.61 |
| SiBone (SIBN) | United States | $0.843B | 0.00 |
| IRadimed (IRMD) | United States | $0.685B | 34.78 |
| Mesa Laboratories (MLAB) | United States | $0.665B | 14.54 |
| Beta Bionics (BBNX) | United States | $0.623B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.43 |
| Delcath Systems (DCTH) | United States | $0.596B | 0.00 |
| RxSight (RXST) | United States | $0.577B | 0.00 |
| NeuroPace (NPCE) | United States | $0.574B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.560B | 0.00 |
| AxoGen (AXGN) | United States | $0.539B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.474B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.311B | 0.00 |
| Neuronetics (STIM) | United States | $0.278B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.196B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.184B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| CVRx (CVRX) | United States | $0.165B | 0.00 |
| 908 Devices (MASS) | United States | $0.164B | 0.00 |
| Inogen (INGN) | United States | $0.164B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.141B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.125B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.092B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 44.60 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.50 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.45 |